| Kenya | Uganda | Ethiopia | Senegal | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
N | % | P -value | N | % | P -value | N | % | P -value | N | % | P -value | |
Percentage of respondents reporting that FGM/C cases before COVID-19 were: | ||||||||||||
  Same as now | 49 | 15.7 | < 0.001 | 1 | 0.4 | 0.216 | 150 | 59.8 | 0.837 | 13 | 6.3 | 0.22 |
  Decreasing | 196 | 62.8 | 257 | 92.4 | 69 | 27.5 | 138 | 66.3 | ||||
  Increasing | 48 | 15.4 | 14 | 5.0 | 32 | 12.7 | 22 | 10.6 | ||||
  Don’t know/ No response | 19 | 6.1 | 6 | 2.2 | 0 | 0.0 | 35 | 16.8 | ||||
Percentage of respondents reporting that FGM/ cases during COVID-19 were: | ||||||||||||
  Same as now | 51 | 16.3 | < 0.001 | 30 | 10.8 | 0.062 | 204 | 81.3 | 0.126 | 22 | 10.6 | 0.592 |
  Decreasing | 81 | 26.0 | 228 | 82.0 | 46 | 18.3 | 134 | 64.4 | ||||
  Increasing | 171 | 54.8 | 19 | 6.8 | 1 | 0.4 | 5 | 2.4 | ||||
  Don’t know/ No response | 9 | 2.9 | 1 | 0.4 | 0 | 0.0 | 47 | 22.6 | ||||
Percentage of respondents reporting that CEFM cases before COVID-19 were: | ||||||||||||
  Same as now | 42 | 13.5 | < 0.001 | 3 | 1.1 | < 0.001 | 124 | 49.4 | 0.655 | 17 | 8.2 | 0.423 |
  Decreasing | 193 | 61.9 | 234 | 84.2 | 75 | 29.9 | 129 | 62.0 | ||||
  Increasing | 67 | 21.5 | 40 | 14.4 | 52 | 20.7 | 27 | 13.0 | ||||
  Don’t know/ No response | 10 | 3.2 | 1 | 0.4 | 0 | 0.0 | 35 | 16.8 | ||||
Percentage of respondents reporting that CEFM cases during COVID-19 were: | ||||||||||||
  Same as now | 45 | 14.4 | < 0.001 | 10 | 3.6 | 0.111 | 175 | 69.7 | 0.712 | 26 | 12.5 | 0.732 |
  Decreasing | 66 | 21.2 | 74 | 26.6 | 60 | 23.9 | 124 | 59.6 | ||||
  Increasing | 198 | 63.5 | 193 | 69.4 | 16 | 6.4 | 27 | 13.0 | ||||
  Don’t know/ No response | 3 | 1.0 | 1 | 0.4 | 0 | 0.0 | 31 | 14.9 | ||||
Total | 312 | 100.0 | Â | 278 | 100.0 | Â | 251 | 100.0 | Â | 208 | 100.0 | Â |